Mechanism of quinolone uptake into bacterial cells

Journal of Antimicrobial Chemotherapy

Volumn 27, Issue 4, 1991, Pages 399-403

  Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFLOXACIN; CIPROFLOXACIN; ENOXACIN; FLEROXACIN; LOMEFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

BACTERIAL MEMBRANE; DRUG UPTAKE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; NONHUMAN; PH; PRIORITY JOURNAL; SHORT SURVEY; TEMPERATURE;

ANTI-INFECTIVE AGENTS, QUINOLONE; GRAM-NEGATIVE BACTERIA;

EID: 0025729724     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/27.4.399     Document Type: Article

References (24)

1. Aoyama, H., Fujimaki, K., Sato, K., Fugii, T., Inouc, M., Hirai, K. et al. (1988). Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrobial Agents and Chemotherapy 32, 922-4.
2. Aoyama, H., Sato, K., Kato, T., Hirai, K. and Mitsuhashi, S. (1987). Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrobial Agents and Chemotherapy 31, 1640-1.
3. Ashby, J., Piddock, L. J. V. and Wise, R. (1985). An investigation of the hydrophobicity of the quinolones. Journal of Antimicrobial Chemotherapy 16, 805-8.
4. Bedard, J. and Bryan, L. E. (1989). Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrobial Agents and Chemotherapy 33, 1379-82.
5. Bedard, J., Chamberland, S., Wong, S., Schollaardt, T. and Bryan, L. E. (1989). Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli. Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. Antimicrobial Agents and Chemotherapy 33, 1457-64.
6. Bedard, J., Wong, S. and Bryan, L. E. (1987). Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrobial Agents and Chemotherapy 31, 1348-54.
7. Celesk, R. A. and Robillard, N. J. (1989). Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 33, 1921-6.
8. Chapman, J. S. and Georgopapadakou, N. H. (1988). Routes of quinolone permeation in Escherichia coli. Antimicrobial Agents and Chemotherapy 32, 438-52.
9. Chapman, J. S. and Georgopapadakou, N. H. (1989). Fluorometric assay for fleroxacin uptake by bacterial cells. Antimicrobial Agents and Chemotherapy 33, 27-9.
10. Cohen, S. P., Hooper, D. C., Wolfson, J. S., Souza, K. S., McMurry, L. M. and Levy, S. B. (1988). Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrobial Agents and Chemotherapy 32, 1187-91.
11. Cohen, S. P., McMurray, L. A., Hooper, D. C, Wolfson, J. S. and Levy, S. B. (1989). Cross-resistance to fluoroquinolones in multiple- antibiotic-resistance (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial Agents and Chemotherapy 33, 1318-25.
12. Diver, J. M., Andrews, J. M., Piddock, L. J. V. and Wise, R. (1988). Investigations into the uptake of ciprofloxacin, enoxacin, and pefloxacin by Escherichia coli. Reviews of Infectious Diseases 10, Suppl. 1, S22-3.
13. Diver, J. M., Piddock, L. J. V. and Wise, R. (1990). The accumulation of five quinolone antibacterial agents by Escherichia coli. Journal of Antimicrobial Chemotherapy 25, 319-33.
14. Easmon, C. S. F. and Crane, J. P. (1985). Uptake of ciprofloxacin by human neutrophils. Journal of Antimicrobial Chemotherapy 16, 67-73.
15. Hancock, R. E. W., Raffle, V. J. and Nicas, T. I. (1981). Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 19, 777-85.
16. Hirai, K., Aoyama, H., Irikura, T., Iyobe, S. and Mutsuhashi, S. (1986a). Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrobial Agents and Chemotherapy 29,535-8.
17. Hirai, K., Aoyama, H., Suzue, S., Irikura, T., Iyobe, S. and Mitsuhashi, S. (1986b). Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K.-12. Antimicrobial Agents and Chemotherapy 30, 248-53.
18. Hirai, K., Suzue, S., Irikura, T., Iyobe, S. and Mitsuhashi, S. (1987). Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 31,582-6.
19. Hooper, D. C., Wolfson, J. S., Souza, K. S., Ng, E. Y., McHugh, G. L. and Schwartz, M. N. (1989). Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistant loci decreasing norfloxacin accumulation. Antimicrobial Agents and Chemotherapy 33, 283-90.
20. Lundrigan, M. D. and Earhart, C. F. (1984). Gene envY of Escherichia coli K12 affects thermoregulation of major porin expression. Journal of Bacteriology 157, 262-8.
21. Masecar, B. L., Celesk, R. A. and Robillard, N. J. (1990). Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 34, 281-6.
22. Nikaido, H. (1979). Nonspecific transport through the outer membrane. In Bacterial Outer Membranes: Biogenesis and Functions (Inouye, M., Ed.), pp. 361-407. John Wiley, New York.
23. Piddock, L. J. V., Hall, M. C. and Wise, R. (1990). Mechanism of action of lomefloxacin. Antimicrobial Agents and Chemotherapy 34, 1088-93.
24. Silvain, C., Breux, J. P., Rochard, E., Bouquet, S., Becq-Giraudon, B. and Beauchant, M. (1987). Decreased erythrocyte penetration of pefioxacin in cirrhotic patients. Journal of Antimicrobial Chemotherapy 20, 290-2.